Mostert Cassidy Q B, Singh Ranjit D, Gerritsen Maxime, Kompanje Erwin J O, Ribbers Gerard M, Peul Wilco C, van Dijck Jeroen T J M
University Neurosurgical Center Holland, Leiden University Medical Center & Haaglanden Medical Center & Haga Teaching Hospital, Leiden The Hague, Albinusdreef 2, J-11-R-83, 2333 ZA, Leiden, The Netherlands.
Department of Intensive Care Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands.
Acta Neurochir (Wien). 2022 Mar;164(3):599-613. doi: 10.1007/s00701-021-05086-6. Epub 2022 Jan 31.
Expectation of long-term outcome is an important factor in treatment decision-making after severe traumatic brain injury (sTBI). Conclusive long-term outcome data substantiating these decisions is nowadays lacking. This systematic review aimed to provide an overview of the scientific literature on long-term outcome after sTBI.
A systematic search was conducted using PubMed from 2008 to 2020. Studies were included when reporting long-term outcome ≥ 2 years after sTBI (GCS 3-8 or AIS head score ≥ 4), using standardized outcome measures. Study quality and risk of bias were assessed using the QUIPS tool.
Twenty observational studies were included. Studies showed substantial variation in study objectives and study methodology. GOS-E (n = 12) and GOS (n = 8) were the most frequently used outcome measures. Mortality was reported in 46% of patients (range 18-75%). Unfavourable outcome rates ranged from 29 to 100% and full recovery was seen in 21-27% of patients. Most surviving patients reported SF-36 scores lower than the general population.
Literature on long-term outcome after sTBI was limited and heterogeneous. Mortality and unfavourable outcome rates were high and persisting sequelae on multiple domains common. Nonetheless, a considerable proportion of survivors achieved favourable outcome. Future studies should incorporate standardized multidimensional and temporal long-term outcome measures to strengthen the evidence-base for acute and subacute decision-making.
对严重创伤性脑损伤(sTBI)后长期预后的预期是治疗决策的一个重要因素。目前缺乏确凿的长期预后数据来支持这些决策。本系统评价旨在概述关于sTBI后长期预后的科学文献。
使用PubMed对2008年至2020年的文献进行系统检索。纳入的研究需报告sTBI(格拉斯哥昏迷量表评分3 - 8分或简明损伤定级(AIS)头部评分≥4分)后≥2年的长期预后,且使用标准化的预后指标。使用QUIPS工具评估研究质量和偏倚风险。
纳入了20项观察性研究。研究显示研究目的和研究方法存在很大差异。扩展格拉斯哥预后量表(GOS-E,n = 12)和格拉斯哥预后量表(GOS,n = 8)是最常用的预后指标。46%的患者报告了死亡率(范围为18% - 75%)。不良预后率在29%至100%之间,21% - 27%的患者实现了完全康复。大多数存活患者报告的SF - 36评分低于一般人群。
关于sTBI后长期预后的文献有限且异质性较大。死亡率和不良预后率较高,多个领域存在持续的后遗症很常见。尽管如此,相当一部分幸存者获得了良好的预后。未来的研究应纳入标准化的多维和长期预后指标,以加强急性和亚急性决策的证据基础。